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 ABSTRACT 
Co-Culture of Equine Mesenchymal Stem Cells with Synoviocytes to Modulate Induced 
Inflammation In-Vitro  
(May 2014) 
 
Vincent C. Fussell 
College of Veterinary Medicine and Biomedical Science 
Texas A&M University 
 
Research Advisor: Dr. Ashlee Watts 
Comparative Orthopedics and Regenerative Medicine Laboratory 
 
 
Stem cells are the current topic of interest when it comes to the forefront of tissue engineering 
and new nonivassive therapies; and at the pennacle of  regenerative medicine for orthopedic 
tissues and immunomodulary treatments stands Mesenchymal Stem Cells (MSC). MSCs have 
demonstrated multiple therapeutic uses due to their abilities to both induce tissue regeneration in 
mutiple mesoderm derived cell lineages, as well as respond to and mediate cellular activity in 
their local environment. 
In order to better understand the ways in which MSCs act to mediate acute inflammation, an 
environmental scenario similar to that of osteoarthritis was created by inducing synovitis in-
vitro. Equine synoviocytes were harvested, plated, and then exposed to the inflammatory 
cytokines TNF-Alpha and IL-1Beta. The synoviocytes suspended in the pro-inflammatory 
cytokines were then treated with autogenic MSCs in order to observe the mechanisms by which 
they would interact with the synoviocytes in order to regulate inflammation. The media 
containing both the mesenchymal stem cells and the inflamed synoviocytes was harvested and 
the concentration of extracellular PGE-2 was analyzed using ELISA in an effort to observe any 
1 
 communication between the two cell types. Synoviocyte proliferation was also observed visually 
by comparing colony formation and cell confluence prior to inflammation, following 
inflammation, and following MSC treatment. Further investigation must be done before 
definitive results can be described. Significant conclusions cannot be drawn based on the 
preliminary data that is currently available.  
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 NOMENCLATURE 
 
bFGF – Basic Fibroblast Growth Factor  
 
BSA – Bovine Serum Albumin 
 
DMEM – Dulbecco’s Modified Eagle’s Medium 
 
DMSO – Dimethyl Sulfoxide 
 
DPBS – Dulbecco’s Phosphate Buffered Saline 
 
ELISA – Enzyme-Linked Immunosorbent Assay 
 
FBS – Fetal Bovine Serum 
 
FDA – Fluorescein Diacetate 
 
HBSS – Hanks Buffered Saline Solution 
 
HEPES – 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
 
IL-1B – Interleukin – 1 Beta 
 
ITS+ - Insulin, Transferrin, Selenium Cell Culture Supplement 
 
MSC – Mesenchymal Stem Cell 
 
MSCi-SF – Serum Free MSC Isolation Media 
 
PBS – Phosphate Buffered Solution 
 
PGE2 – Prostaglandin E2 
 
SIM – Synoviocyte Isolation Media 
 
TCEP – tris(2-carboxyethyl)phosphine 
 
TNF-A – Tumor Necrosis Factor - Alpha 
 
Tris – (Hydroxymethyl)-aminomethane 
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CHAPTER I 
INTRODUCTION 
 
Mesenchymal Stem Cells (MSCs), also known as Marrow Stem Cells, Multipotent Stromal Cells 
or Mesenchymal Sticky Cells, are multi-potent stromal cells that can differentiate into multiple 
cell lineages including the orthopedic tissues composed of adipocytes, chondrocytes, and 
osteocytes.
1,3
 During embryonic development, MSCs arise during embryonic trunk development 
from SOX1(+) neuroepithelial cells in the mesoderm.
2
 Morphologically, MSCs are characterized 
by their fibroblast-like appearance, with long slender cell processes and a small cell body.
4
 As 
stem cells, MSCs are characterized by their ability to undergo self-renewal while maintaining 
their multipotency.
7
 While the majority of MSCs are derived from red bone marrow, other 
sources of MSCs include muscle tissue, adipose tissue, amniotic fluid, umbilical cord blood, and 
a variety of other tissues.
7
 In horses, MSCs are most often harvested from the bone marrow of 
sternum. The primary method of isolating MSCs from a population of marrow derived cells is 
attributed to their novel ability to adhere to plastic.
1
 Other cells can be washed from the isolate 
before the MSCs are collected by trypsinization.  
MSC populations are also characterized by the expression of specific cell surface markers which 
can be identified with the use of a flow cytometer. The accuracy of these specific cell surface 
markers in representing a population of MSCs, and what precise characteristics are expressed by 
a true MSC are currently topics of debate. However, it is generally accepted that expression of 
the cell surface markers STRO-1, VCAM-1, CD-105, CD-90, and CD-73, and the lack of 
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 expression of MHC-II, CD-79a, CD-45, CD-34, CD-19, CD-14, and CD-11b, is representative of 
a population of mesenchymal stem cells.
1,5,7
  
Since MSCs have the ability to generate multiple lines of mesoderm derived tissues, it is obvious 
that their primary application is in tissue regeneration and tissue engineering. MSCs have 
successfully demonstrated these regenerative abilities on multiple occasions in a variety of 
different situations; from repairing tendons and cartilaginous defects, to being used to engineer 
customized bones, to being inserted in absorbable matrices to repair tendons and ligaments, to 
treatment of osteogenesis imperfect in children.
6,11-15
 Once MSCs are injected, exogenous MSC 
populations are recruited to site of an injury by the presence of signaling cytokines such as SDF-
1.
10,16
 By the same mechanism, endogenous MSCs located in their natural niche are mobilized to 
assist in natural tissue repair.
9,10,16
 
 
In addition to their regenerative abilities, MSCs are also known for their pleiotropic nature, being 
able to respond to stimuli from their local environment via both direct cell to cell contact and 
contact independent mechanisms.
3
 Because of this, MSCs possess the ability to regulate their 
local environment and mediate inflammation via paracrine activity, secreting cytokines and 
growth factors that have a variety of roles in stimulating endogenous cell populations.
8,9 
The 
mechanisms by which this is done include suppressing the immune system by regulating T-Cell 
proliferation, inhibiting fibrosis and apoptosis, and stimulating angiogenesis, cell proliferation, 
and cell differentiation to enhance tissue repair.
3,8,9
 The pro-inflammatory cytokines in the tumor 
necrosis factor family and interleukin family, such as TNF-α and IL-1β, are commonly found in 
particularly abundant concentrations in the synovial lining of inflamed joints.
3
 One of the 
proposed mechanisms in which MSCs regulate acute inflammation in their microenvironment is 
by the secretion cytokines such as prostaglandin (PGE-2).
3,16
 Because of their ability as trophic-
6 
 mediators, MSCs could potentially be powerful tools when it comes to future treatment methods 
for joint inflammation and diseases such as rheumatoid arthritis and gout.
17
 
The possible clinical applications for MSCs are vast, ranging from utilizing their regenerative 
capabilities in order to combat defects in orthopedic tissue, to utilizing their anti-inflammatory 
properties to ameliorate the symptoms of arthritis.
3,17 
This experiment will focus primarily on the 
mechanisms in which MSCs act to mediate inflammation and communicate with other cells in 
their local environment. Specifically, how MSCs respond when exposed to an environment of 
synoviocytes in either TNF-A or IL-1B in-vitro. A better understanding of how these cells act in-
vitro will help in developing future clinical applications for MSCs in-vivo.  
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 CHAPTER II 
METHODS AND MATERIALS 
 
Equine synoviocytes were isolated from the synovial membrane of the 
metacarpo(tarso)phalangeal joints of horses euthanized for reasons unrelated to this study. The 
synovial membrane was treated with 10mL/g of digest media consisting of 1.5mg/mL 
Collagenase, 0.15mg/mL of DNase, and synoviocyte isolation media (SIM), consisting of 500ml 
of High Glucose DMEM mixed with 12.5mL of 1M HEPES, 5mL of 200mM L-Glutamine, and 
5mL of sodium pyruvate, along with 50mL of fetal bovine serum (FBS) and 5mL of 
Penicillin/Streptomycin (10,000 IU/mL Pen, 10,000ug/mL Strep stock) and plated for 2-3 days 
until confluent. The plated synoviocytes were then treated with 5mL of trypsin to remove them 
from the plastic flask and treated with 5mL of 10% equine serum in order to neutralize the 
trypsin and protect the synoviocyte cells from proteolytic cleavage.  The synoviocytes were then 
rinsed with 10 ml of DPBS and cryopreserved in a solution consisting of 10mL of FBS, 10mL of 
dimethyl sulfoxide (DMSO), and 80mL of SIM until use.  
Autologous mesenchymal stem cells were isolated from bone marrow collected from the sternum 
of each of the horses used for collecting synovium. Raw marrow was spun down and 
erythrocytes were lysed using 1X Tris-NH4Cl Lyses Solution (pH of 7.2) which consisted of 7.7g 
of NH4Cl and 2.06g of Tris (Hydroxymethyl)-aminomethane dissolved in 1L of deionized water. 
Bone marrow was treated with the lyses solution twice in proportions of 20mL lyses solution per 
mL of bone marrow. Cells were centrifuged and lyses solution was aspirated between treatments. 
Remaining lyses solution was aspirated and the cells were then suspended in 10mL of MSC 
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 isolation media consisting of 500mL of Low-Glucose (1g/dL Glucose) DMEM mixed with 
12.5mL of 1M HEPES, 5mL of 200mM L-Glutamine, 5mL of sodium pyruvate and 5mL of 
fungizome. The MSCs were then plated in T175 flasks and suspended in an equal volume of 
MSC isolation media (without fungizome) in order to expand cell populations. The MSCs were 
incubated at 37 degrees Celsius for 7 to 10 days until the cells grew into a 70% confluent 
monolayer. During that time media was replaced approximately every 48 hours.  Once the cells 
reached confluence, media was aspirated and the flask was washed with 10mL of HBSS. Cells 
were then treated with 5mL of trypsin and incubated for 5 minutes to speed up separation of the 
cells from the flask. The cells were then treated with 5mL of HBSS to neutralize the trypsin. 
Lastly, the cells were aspirated from the flask, centrifuged to remove the supernatant, and 
cryopreserved in a solution composed of 10mL FBS, 10mL DMSO, and 80mL MSC isolation 
media.  
A stock solution of sterile 0.1% bovine serum albumin (BSA) in 1X Phosphate Buffered 
Solution (PBS) was made under a laminar flow hood. The inflammatory cytokines TNF-A and 
IL-1B were reconstituted in the stock solution of 0.1% BSA in 1X PBS to concentration of 
10ng/uL for each. Three six well Corning plates were labeled for each of the 3 conditions tested: 
Synoviocytes Only, MSC Synoviocyte Co-Culture, and MSCs Only. For each of the three plates, 
two wells were designated for each of the inflammatory conditions: TNF-A, IL-1B, and Control.  
Synoviocytes were thawed, re-suspended in DPBS, and spun down at 300G for 4 minutes. 
Following this initial rinse the DPBS was then aspirated off and the synoviocytes were re-
suspended in 20 mL of SIM. 100uL of the synoviocyte cell suspension was added to a solution 
composed of 60uL of propidium iodide, 740uL of HBSS, and 100ul of a mixture of 10uL of 
fluorescein diacetate (FDA) and 2.5mL of DPBS. The synoviocytes were then counted using a 
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 hemocytometer and fluorescent microscopy. Initial counts were used to estimate the number of 
live cells recovered post thaw by multiplying the number of live cells by the volume of SIM they 
were suspended in and then 10,000 to account for the sample size measured by the 
hemocytometer. Following counting, 100,000 synoviocytes were plated in each of the spot wells 
of the “Synoviocytes Only” plate, and 50,000 synoviocytes were plated in each of the spot wells 
of the “MSC Synoviocyte Co-Culture” plate. Each spot well received a volume of cells not to 
exceed 2 mL and additional SIM was added so that the volume in each spot well was exactly 2 
mL. The “MSCs Only” spot wells received only 2mL of SIM. Cells were incubated at 37 C for 
8-12 hours following plating. 
Plates were inspected at 40x and 100x magnification following incubation. Media from each spot 
well was then aspirated and each spot well was rinsed with 2mL of Hank’s Balanced Salt 
Solution (HBSS) before the addition of 2 mL of serum free MSC Isolation media (MSCi-SF), 
consisting of 500mL of Low-Glucose (1g/dL Glucose) DMEM (also mixed with 12.5mL of 1M 
HEPES, 5mL of 200mM L-Glutamine, and 5mL of sodium pyruvate) along with 5mL of ITS+ 
(.01X Concentration of Stock), 5uL of (1ng/mL) bFGF, 5mL Penicillin/Streptomycin (50,000 U 
Antibiotic) and 1mL of Amphotericin B. Each of the spot wells were then inflamed with 1 uL of 
their respective inflammatory cytokine reconstituted in 0.1% BSA in 1X PBS. Control wells 
received only 1 uL of the stock solution of 0.1% BSA in 1X PBS. The synoviocytes were 
incubated at 37 C for 4-6 hours while being exposed to the inflammatory mediators. Spot wells 
were again inspected after the 4-6 hour exposure period. 
In a separate vial, autogenic MSCs were thawed, re-suspended in DPBS, and spun down at 300G 
for 4 minutes. The DPBS was aspirated off and the MSCs were re-suspended in 20 mL of MSCi-
SF. The MSCs were then counted using the same procedure for the synoviocytes. Following 
10 
 counting, 100,000 MSCs were plated in each of the spot wells for the “MSCs Only” plate, and 
50,000 MSCs were plated in each of the spot wells for the “MSC Synoviocyte Co-Culture” plate. 
Each spot well received a volume of cells not to exceed 1 mL and additional MSCi-SF was 
added so that the volume added to each spot well was exactly 1mL. The “Synoviocyte Only” 
spot wells received 1mL of only MSCi-SF. The plates were then incubated for 24 hours at 37 C. 
After the 24 hour incubation period, media was harvested in 560uL aliquots in 1.5mL 
microcentrifuge tubes. The tubes were then frozen at -20 C and the remainder of the media was 
aspirated.  
Protein analysis was done via ELISA using a Prostaglandin E2 Parameter Assay Kit from R&D 
Systems. 2 and 3, and later 5 and 10 fold dilutions of the harvested media were done prior to 
running each ELISA plate. Concentration of PGE2 was measured by observation of the relative 
absorbance at 450nm following binding of fluorescent conjugate.  
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 CHAPTER III 
RESULTS 
 
Thus far, ELISA data for all of the horses co-cultured has been both inaccurate and inconclusive. 
No pattern in absorbace was expressed between the different dilution factors of each of the 
samples or by the stepwise dilution of the PGE-2 standard provided by the kit. Because of the 
inconsitancy of the ELISA plates to provide From the current ELISA data, the only observation 
that can be made is that higher concentrations of PGE-2 were detected for each conditions of the 
“MSC Only” culture when compared to the “Synoviocyte Only” and “Co-Culture.” However, the 
actual concentration of PGE-2 in the samples cannot yet be quantified, and the actuall 
significance, if any, cannot be determined.  
 
 
 
1 2 3 4 5 6 7 8 9 10 11 12
A 2500 2500 TNF-1L TNF-1L C-1L C-1L IL-1L IL-1L TNF-1L TNF-1L C-1L C-1L
B 1250 1250 TNF-1H TNF-1H C-1H C-1H IL-1H IL-1H TNF-1H TNF-1H C-1H C-1H
C 625 625 TNF-2L TNF-2L C-2L C-2L IL-2L IL-2L TNF-2L TNF-2L C-2L C-2L
D 313 313 TNF-2H TNF-2H C-2H C-2H IL-2H IL-2H TNF-2H TNF-2H C-2H C-2H
E 156 156 IL-1L IL-1L TNF-1L TNF-1L C-1L C-1L IL-1L IL-1L
F 78 78 IL-1H IL-1H TNF-1H TNF-1H C-1H C-1H IL-1H IL-1H
G 39 39 IL-2L IL-2L TNF-2L TNF-2L C-2L C-2L IL-2L IL-2L
H 0 0 IL-2H IL-2H TNF-2H TNF-2H C-2H C-2H IL-2H IL-2H NSB NSB
1 2 3 4 5 6 7 8 9 10 11 12
A 0.198 0.236 0.172 0.27 0.218 0.226 0.226 0.213 0.541 0.445 0.606 0.511
B 0.16 0.376 0.144 0.207 0.199 0.287 0.228 0.163 0.478 0.476 0.508 0.306
C 0.195 0.297 0.167 0.252 0.23 0.292 0.156 0.15 0.5 0.216 0.567 0.273
D 0.185 0.425 0.324 0.209 0.19 0.247 0.211 0.297 0.488 0.342 0.561 0.515
E 0.183 0.196 0.162 0.164 0.165 0.254 0.231 0.153 0.588 0.455
F 0.172 0.198 0.152 0.162 0.229 0.271 0.236 0.17 0.484 0.304
G 0.082 0.063 0.333 0.205 0.247 0.421 0.243 0.168 0.446 0.391
H 0.024 0.041 0.168 0.313 0.356 0.273 0.506 0.492 0.489 0.43 0.002 -0.002
Table 1 - ELISA Plate Layout  
Black (1-2:A-H): Standard Dilution   Red (3-4:A-H, 5-6:A-D): Co-Culture   
Blue (5-6:E-H, 7-8:A-H): Synoviocytes Only  Green (9-10:A-H, 11-12:A-D): MSCs Only 
Table 2 – ELISA Absorbance at 540nm (Corrected)  
(Comparison of the absorbance of different dilutions exemplifies the inaccuracy of the ELIZA plate) 
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 From visual inspection of the cultures, it appears that the cells of the “Synoviocyte Only” culture 
are healthier compared to the “Co-Culture” MSCs and synoviocyte cells. Likewise, the cells in 
the “MSC Only” culture appear healthier and more confluent compared to the cells of the Co-
Culture.  
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Figure 1 – “Synoviocytes Only”  
Pre-Inflammation (T = 24 Hours) 
Figure 2 (Left) – “Synoviocytes Only”  
Post-Inflammation (T = 48 Hours) 
Control 
 
 
Figure 3 (Right) – “Co-Culture” 
Post-Inflammation (T = 48Hours) 
Control 
Figure 6 (Left) – “Synoviocytes Only”  
Post-Inflammation (T = 48 Hours) 
TNF-α 
 
 
Figure 7 (Right) – “Co-Culture” 
Post-Inflammation (T = 48Hours) 
TNF-α 
Figure 4 (Left) – “Synoviocytes Only”  
Post-Inflammation (T = 48 Hours) 
IL-1β 
 
 
Figure 5 (Right) – “Co-Culture” 
Post-Inflammation (T = 48Hours) 
IL-1β 
 CHAPTER IV 
DISCUSSION 
 
While the reported data is inconclusive, it is important to remember that results from this 
experiment are still preliminary. ELISA plates for these preliminary horses will be redone using 
a kit from a different supplier. Hopefully, differences between the different cell cultures, as well 
differences between the inflammatory conditions will then be observed. Statistical significance 
will be determined once accurate data is generated and compiled for the new ELISA plates. 
From this experiment, it was expected that the inflammed synviocytes co-cultured with MSCs 
would have higher concentrations of PGE-2, since it is suspected that MSCs secrete PGE-2  as a 
paracrine mechanism to communicate with cells in their local environment in order to reduce the 
prevalence of pro-inflammatory cytokines. Also, minimal PGE-2 would ideally be observed in 
the “synoviocyte only” condition which will prove that secretion of PGE-2 and inflammatory 
regulation is specifically attributed to MSC activity. However, from the preliminary ELISA data, 
it appears that the media of the “MSC Only” culture contained the highest concentrations of 
PGE-2. While this does follow the latter hypothesis that secretion of PGE-2 will be attributed to 
MSC activity in mediating the local environment, it does not explain why the ammount of PGE-2 
is not similarly elevated in the Co-Culture media. One possible explanation for this initial 
observation is that the MSCs in the “MSC Only” culture did not have any cells to communicate 
with in their microenvironment. For this reason, the cells secreted more PGE-2 in an effort to 
mediate the environment when no change in stimuli occurred following the intial secretion of 
PGE-2. Another possible explanation for the observed elevated concentrations of PGE-2 may be 
14 
 due to the conditions established by the experimental protocol. The “MSC Only” culture had 
100,000 MSCs plated why the “Co-Culture” had only 50,000 MSCs plated. Despite this, it would 
still be expected that there would be an intermediate elevated level of PGE-2 concentration in the 
“Co-Culture” when compared to the concentrations of PGE-2 in the “MSC Only” and 
“Synoviocyte Only” cultures. A possible continuation to this experiment would be to observe 
another Co-Culture in which the synoviocytes are treated with 100,000 MSCs for comparison 
agains the “MSC Only” culture. 
Similair logic can be applied to give a possible explanation for the observed visual differences 
between the “Co-Culture” and “Synoviocyte Only” cultures. It was expected that in this 
experiment the inflammed synviocytes in the “Co-Culture” would appear healthier and more 
confluent following treatment with MSCs due to the MSCs mediating the effects of the pro-
inflammatory cytokines in the media. However, it appears that the synoviocytes in the Co-
Culture are less healthy and less confluent compared to the “Synviocyte Only” culture. A 
possible explanation for the observed difference may again be due to the difference in the 
number of cells that were plated in the different cultures. Only 50,000 synoviocytes were plated 
in the “Co-Culture” while 100,000 synoviocytes were plated in the “Synoviocyte Only” culture. 
For this reason, the “Synoviocyte Only” culture may appear to be healthier and more confluent 
simply because twice as many synoviocytes were plated to begin with. 
Following ELISA, this experiment will be continued by using qRT-PCR in order to observe what 
transcripts are present in the cell lysate. From this, the products that are being actively 
transcribed by the cells can be determined. This, in conjunction with the results from ELISA, 
will give a more definite reference as to how MSCs are acting under the applied conditions to 
mediate their environment. 
15 
 Lastly, this experiment can be improved upon by positively identifying the isolated cell 
populations prior to the co-culture portion of the experiment. Flow cytometry can be used in 
order to determine that the isolated cells express the cell surface markers for either MSCs or 
synoviocyte cells. Validation that these cell populations are being used is necessary to determine 
that MSCs are the cells responsible for any observed differences between the different cell 
culture conditions. Overall, further investigation is required before conclusions can be made 
based on the experimental results.  
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